Exelixis Inc (EXEL)
22.70
-0.11
(-0.48%)
USD |
NASDAQ |
Apr 15, 16:00
22.69
-0.01
(-0.04%)
After-Hours: 20:00
Exelixis Total Liabilities (Quarterly): 678.44M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 678.44M |
| September 30, 2023 | 629.29M |
| June 30, 2023 | 614.53M |
| March 31, 2023 | 588.22M |
| December 31, 2022 | 583.06M |
| September 30, 2022 | 469.97M |
| June 30, 2022 | 490.14M |
| March 31, 2022 | 360.27M |
| December 31, 2021 | 405.62M |
| September 30, 2021 | 335.29M |
| June 30, 2021 | 324.19M |
| March 31, 2021 | 279.36M |
| December 31, 2020 | 258.22M |
| September 30, 2020 | 259.01M |
| June 30, 2020 | 213.22M |
| March 31, 2020 | 207.95M |
| December 31, 2019 | 199.70M |
| September 30, 2019 | 181.15M |
| June 30, 2019 | 154.47M |
| March 31, 2019 | 156.77M |
| December 31, 2018 | 134.83M |
| September 30, 2018 | 108.40M |
| June 30, 2018 | 136.19M |
| March 31, 2018 | 105.15M |
| December 31, 2017 | 370.33M |
| Date | Value |
|---|---|
| September 30, 2017 | 371.06M |
| June 30, 2017 | 368.02M |
| March 31, 2017 | 467.23M |
| December 31, 2016 | 506.42M |
| September 30, 2016 | 516.47M |
| June 30, 2016 | 663.27M |
| March 31, 2016 | 648.49M |
| December 31, 2015 | 473.15M |
| September 30, 2015 | 437.47M |
| June 30, 2015 | 436.97M |
| March 31, 2015 | 429.69M |
| December 31, 2014 | 438.10M |
| September 30, 2014 | 442.17M |
| June 30, 2014 | 437.39M |
| March 31, 2014 | 426.08M |
| December 31, 2013 | 437.05M |
| September 30, 2013 | 423.20M |
| June 30, 2013 | 415.75M |
| March 31, 2013 | 404.68M |
| December 31, 2012 | 424.66M |
| September 30, 2012 | 421.77M |
| June 30, 2012 | 275.44M |
| March 31, 2012 | 280.25M |
| December 31, 2011 | 302.63M |
| September 30, 2011 | 408.58M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
154.47M
Minimum
Jun 2019
678.44M
Maximum
Dec 2023
380.64M
Average
335.29M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 7.107B |
| Bristol-Myers Squibb Co | 65.67B |
| Incyte Corp | 1.592B |
| Bio-Techne Corp | 767.19M |
| Legend Biotech Corp | 597.24M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.942B |
| Shareholders Equity (Quarterly) | 2.264B |
| Current Ratio | 3.343 |